Nitric oxide and nanotechnology: A novel approach to inhibit neointimal hyperplasia

Journal of Vascular Surgery

Volumn 47, Issue 1, 2008, Pages 173-182

  Kapadia, Muneera R ^a   Chow, Lesley W ^a   Tsihlis, Nick D ^a   Ahanchi, Sadaf S ^a   Eng, Jason W ^a   Murar, Jozef ^a   Martinez, Janet ^a   Popowich, Daniel A ^a   Jiang, Qun ^a   Hrabie, Joseph A ^b   Saavedra, Joseph E ^b   Keefer, Larry K ^c   Hulvat, James F ^a   Stupp, Samuel I ^a   Kibbe, Melina R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [N (3 AMINOPROPYL) N (3 AMMONIOPROPYL)]DIAZEN 1 IUM 1,2 DIOLATE; AMPHOPHILE; DISODIUM 1 [(2 CARBOXYLATO)PYRROLIDIN 1 YL]DIAZEN 1 IUM 1,2 DIOLATE; HEPARIN; NANOFIBER; NITRIC OXIDE; PEPTIDE; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; CAROTID ARTERY; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; GEL; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTIMA; MALE; NANOTECHNOLOGY; NONHUMAN; PRIORITY JOURNAL; RAT; SCANNING ELECTRON MICROSCOPY; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; CAROTID ARTERIES; CAROTID ARTERY INJURIES; CELL DEATH; CELL PROLIFERATION; CELLS, CULTURED; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; DRUG COMPOUNDING; ENDOTHELIUM, VASCULAR; GELS; HYPERPLASIA; MALE; MODELS, MOLECULAR; MOLECULAR STRUCTURE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; NANOTECHNOLOGY; NITRIC OXIDE; NITRIC OXIDE DONORS; PROLINE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS; TUNICA INTIMA;

EID: 37549046849     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.09.005     Document Type: Article

References (50)

1. Rosamond W., Flegal K., Friday G., Furie K., Go A., Greenlund K., et al. Heart disease and stroke statistics - 2007 update - A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) E69-E171
2. Bredt D.S., and Snyder S.H. Nitric oxide: a physiologic messenger molecule. Annu Rev Biochem 63 (1994) 175-195
3. Radomski M.W., Palmer R.M., and Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 2 (1987) 1057-1058
4. Kubes P., Suzuki M., and Granger D.N. Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc Natl Acad Sci U S A 88 (1991) 4651-4655
5. Garg U.C., and Hassid A. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83 (1989) 1774-1777
6. Dubey R.K., Jackson E.K., and Lüscher T.F. Nitric oxide inhibits angiotensin II-induced migration of rat aortic smooth muscle cell. Role of cyclic-nucleotides and angiotensin1 receptors. J Clin Invest 96 (1995) 141-149
7. Tzeng E., Kim Y.M., Pitt B.R., Lizonova A., Kovesdi I., and Billiar T.R. Adenoviral transfer of the inducible nitric oxide synthase gene blocks endothelial cell apoptosis. Surgery 122 (1997) 255-263
8. Ziche M., Morbidelli L., Masini E., Amerini S., Granger H.J., Maggi C.A., et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 94 (1994) 2036-2044
9. Ignarro L.J., Buga G.M., Wood K.S., Byrns R.E., and Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci U S A 84 (1987) 9265-9269
10. Lee J.S., Adrie C., Jacob H.J., Roberts J.D.J., Zapol W.M., and Bloch K.D. Chronic inhalation of nitric oxide inhibits neointimal formation after balloon-induced arterial injury. Circ Res 78 (1996) 337-342
11. Davies M.G., Kim J.H., Dalen H., Makhoul R.G., Svendsen E., and Hagen P.O. Reduction of experimental vein graft intimal hyperplasia and preservation of nitric oxide-mediated relaxation by the nitric oxide precursor L-arginine. Surgery 116 (1994) 557-568
12. McNamara D.B., Bedi B., Aurora H., Tena L., Ignarro L.J., Kadowitz P.J., et al. L-arginine inhibits balloon catheter-induced intimal hyperplasia. Biochem Biophys Res Commun 193 (1993) 291-296
13. Chen C., Mattar S.G., and Lumsden A.B. Oral administration of L-arginine reduces intimal hyperplasia in balloon-injured rat carotid arteries. J Surg Res 82 (1999) 17-23
14. Groves P.H., Banning A.P., Penny W.J., Newby A.C., Cheadle H.A., and Lewis M.J. The effects of exogenous nitric oxide on smooth muscle cell proliferation following porcine carotid angioplasty. Cardiovasc Res 30 (1995) 87-96
15. von der Leyen H.E., Mann M.J., and Dzau V.J. Gene inhibition and gene augmentation for the treatment of vascular proliferative disorders. Seminars in Interventional Cardiology 1 (1996) 209-214
16. Chen L., Daum G., Forough R., Clowes M., Walter U., and Clowes A.W. Overexpression of human endothelial nitric oxide synthase in rat vascular smooth muscle cells and in balloon-injured carotid artery. Circ Res 82 (1998) 862-870
17. Janssens S., Flaherty D., Nong Z., Varenne O., Van Pelt N., Haustermans C., et al. Human endothelial nitric oxide synthase gene transfer inhibits vascular smooth muscle cell proliferation and neointima formation after balloon injury in rats. Circulation 97 (1998) 1274-1281
18. Varenne O., Pislaru S., Gillijns H., Van Pelt N., Gerard R.D., Zoldhelyi P., et al. Local adenovirus-mediated transfer of human endothelial nitric oxide synthase reduces luminal narrowing after coronary angioplasty in pigs. Circulation 98 (1998) 919-926
19. Kibbe M.R., Tzeng E., Gleixner S.L., Watkins S.C., Kovesdi I., Lizonova A., et al. Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia. J Vasc Surg 34 (2001) 156-165
20. Shears L.L., Kibbe M.R., Murdock A.D., Billiar T.R., Lizonova A., Kovesdi I., et al. Efficient inhibition of intimal hyperplasia by adenovirus-mediated inducible nitric oxide synthase gene transfer to rats and pigs in vivo. J Am Coll Surg 187 (1998) 295-306
21. Wang K., Kessler P.D., Forudi F., Zhou Z., Zhou X., Tarakji K., et al. Local adenoviral-mediated inducible nitric oxide synthase (iNOS) gene transfer inhibits neointimal formation in the porcine coronary stented model. Am J Cardiol 88 (2001) 51G-52G
22. Marks D.S., Vita J.A., Folts J.D., Keaney J.F.J., Welch G.N., and Loscalzo J. Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest 96 (1995) 2630-2638
23. Schwarzacher S.P., Lim T.T., Wang B.Y., Kernoff R.S., Niebauer J., Cooke J.P., et al. Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty. Circulation 95 (1997) 1863-1869
24. Chaux A., Ruan X.M., Fishbein M.C., Ouyang Y., Kaul S., Pass J.A., et al. Perivascular delivery of a nitric oxide donor inhibits neointimal hyperplasia in vein grafts implanted in the arterial circulation. J Thorac Cardiovasc Surg 115 (1998) 604-612
25. Fulton G.J., Davies M.G., Barber L., Gray J.L., Svendsen E., and Hagen P.O. Local effects of nitric oxide supplementation and suppression in the development of intimal hyperplasia in experimental vein grafts. Eur J Vasc Endovasc Surg 15 (1998) 279-289
26. Kaul S., Cercek B., Rengstrom J., Xu X.P., Molloy M.D., Dimayuga P., et al. Polymeric-based perivascular delivery of a nitric oxide donor inhibits intimal thickening after balloon denudation arterial injury: role of nuclear factor-kappaB. J Am Coll Cardiol 35 (2000) 493-501
27. Harnek J., Zoucas E., Sjuve R., Arner A., Ekblad E., Schou H., et al. Local infusion of the nitric oxide donor SIN-1 after angioplasty - Effects on intimal hyperplasia in porcine coronary arteries. Acta Radiologica 44 (2003) 395-402
28. Yoon J., Wu C.J., Homme J., Tuch R.J., Wolff R.G., Topol E.J., et al. Local delivery of nitric oxide from an eluting stent to inhibit neointimal thickening in a porcine coronary injury model. Yonsei Medi J 43 (2002) 242-251
29. Hou D.M., Narciso H., Kamdar K., Zhang P., Barclay B., and March K.L. Stent-based nitric oxide delivery reducing neointimal proliferation in a porcine carotid overstretch injury model. Cardiovasc Interventional Radiology 28 (2005) 60-65
30. Kown M.H., Yamaguchi A., Jahncke C.L., Miniati D., Murata S., Grunenfelder J., et al. L-arginine polymers inhibit the development of vein graft neointimal hyperplasia. J Thorac Cardiovasc Surg 121 (2001) 971-980
31. Keefer L.K. Progress toward clinical application of the nitric oxide-releasing diazeniumdiolates. Annu Rev Pharmacol Toxicol 43 (2003) 585-607
32. Rajangam K., Behanna H.A., Hui M.J., Han X.Q., Hulvat J.F., Lomasney J.W., et al. Heparin binding nanostructures to promote growth of blood vessels. Nano Lett 6 (2006) 2086-2090
33. Behanna H.A., Rajangam K., and Stupp S.I. Modulation of fluorescence through coassembly of molecules in organic nanostructures. J Am Chem Soc 129 (2007) 321-327
34. Hrabie J.A., and Keefer L.K. Chemistry of the nitric oxide-releasing diazeniumdiolate ("nitrosohydroxylamine") functional group and its oxygen-substituted derivatives. Chem Rev 102 (2002) 1135-1154
35. Saavedra J.E., Southan G.J., Davies K.M., Lundell A., Markou C., Hanson S.R., et al. Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J Med Chem 39 (1996) 4361-4365
36. Hrabie J.A., Klose J.R., Wink D.A., and Keefer L.K. New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem 58 (1993) 1472-1476
37. Kibbe M.R., Li J., Nie S., Watkins S.C., Lizonova A., Kovesdi I., et al. Inducible nitric oxide synthase (iNOS) expression upregulates p21 and inhibits vascular smooth muscle cell proliferation through p42/44 mitogen-activated protein kinase activation and independent of p53 and cyclic guanosine monophosphate [In Process Citation]. J Vasc Surg 31 (2000) 1214-1228
38. Yu S.M., Hung L.M., and Lin C.C. cGMP-elevating agents suppress proliferation of vascular smooth muscle cells by inhibiting the activation of epidermal growth factor signaling pathway. [see comments]. Circulation 95 (1997) 1269-1277
39. Clowes A.W., Reidy M.A., and Clowes M.M. Mechanisms of stenosis after arterial injury. Lab Invest 49 (1983) 208-215
40. Clowes A.W., Reidy M.A., and Clowes M.M. Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest 49 (1983) 327-333
41. Fingerle J., Johnson R., Clowes A.W., Majesky M.W., and Reidy M.A. Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci U S A 86 (1989) 8412-8416
42. Davies M.G., and Hagen P.O. Pathobiology of intimal hyperplasia. Br J Surg 81 (1994) 1254-1269
43. Moller M., Botti H., Batthyany C., Rubbo H., Radi R., and Denicola A. Direct measurement of nitric oxide and oxygen partitioning into liposomes and low density lipoprotein. J Biol Chem 280 (2005) 8850-8854
44. Masters K.S., Lipke E.A., Rice E.E., Liel M.S., Myler H.A., Zygourakis C., et al. Nitric oxide-generating hydrogels inhibit neointima formation. J Biomater Sci Polym Ed 16 (2005) 659-672
45. Lipke E.A., and West J.L. Localized delivery of nitric oxide from hydrogels inhibits neointima formation in a rat carotid balloon injury model. Acta Biomater 1 (2005) 597-606
46. Silva G.A., Czeisler C., Niece K.L., Beniash E., Harrington D.A., Kessler J.A., et al. Selective differentiation of neural progenitor cells by high-epitope density nanofibers. Science 303 (2004) 1352-1355
47. Beniash E., Hartgerink J.D., Storrie H., Stendahl J.C., and Stupp S.I. Self-assembling peptide amphiphile nanofiber matrices for cell entrapment. Acta Biomaterialia 1 (2005) 387-397
48. Harrington D.A., Cheng E.Y., Guler M.O., Lee L.K., Donovan J.L., Claussen R.C., et al. Branched peptide-amphiphiles as self-assembling coatings for tissue engineering scaffolds. J Biomed Mater Res Part A 78a (2006) 157-167
49. Guler M.O., Hsu L., Soukasene S., Harrington D.A., Hulvat J.F., and Stupp S.I. Presentation of RGDS epitopes on self-assembled nanofibers of branched peptide amphiphiles. Biomacromolecules 7 (2006) 1855-1863
50. Saavedra J.E., Mooradian D.L., Mowery K.A., Schoenfisch M.H., Citro M.L., Davies K.M., et al. Conversion of a polysaccharide to nitric oxide-releasing form. Dual mechanism anticoagulant activity of diazeniumdiolated heparin. Bioorg Med Chem Lett 10 (2000) 751-753